OraSure Technologies

Based in Bethlehem, Pennsylvania, OraSure Technologies develops, manufactures and markets point-of-care, oral fluid specimen collection devices that leverage proprietary oral fluid technologies, diagnostic products, including immunoassays and other in vitro diagnostic tests, and other medical devices. These products include tests for the detection of antibodies for the HIV virus, including OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test and the OraSure® HIV-1 Oral Specimen Collection Device, and oral fluid testing solutions for drugs of abuse testing, including Intercept® Oral Fluid Drug Testing System and Q.E.D.® Saliva Alcohol Test. These products are sold in the United States, as well as internationally, to various clinical laboratories, hospitals, clinics, community-based organizations, public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities. The Company also manufactures and sells several leading cryosurgical products. These include: Histofreezer®, a medical professional product for the cryosurgical removal of common, flat and plantar warts, and other benign skin lesions, sold to the professional or physician office market in the United States and many foreign countries. The Company also manufactures and sells an over-the-counter product for the cryosurgical removal of common and plantar warts, available in the United States, Canada, Mexico, certain European countries, Australia and New Zealand.
Bethlehem, US
326 (est)+2%

OraSure Technologies Locations

Bethlehem, US
Bethlehem, US
Bethlehem, US

OraSure Technologies Metrics

OraSure Technologies Summary

Founding Date


Market capitalization

$466 M

Closing share price


OraSure Technologies Market Value History

OraSure Technologies News

OraSure Technologies Company Life

You may also be interested in